Matthew D Walter Net Worth

What's Matthew Walter's mailing address?

Matthew's mailing address filed with the SEC is 109 SOUTH HIGH STREET, , DUBLIN, OH, 43017.

Insiders trading at Cardinal Health

Over the last 23 years, insiders at Cardinal Health have traded over $135,712,519 worth of Cardinal Health stock and bought 2,709 units worth $199,571 . The most active insiders traders include Dean A Scarborough, George S Barrett oraz Jeffrey William Henderson. On average, Cardinal Health executives and independent directors trade stock every 32 days with the average trade being worth of $5,146,997. The most recent stock trade was executed by Jessica L Mayer on 21 August 2024, trading 16,573 units of CAH stock currently worth $1,812,920.

What does Cardinal Health do?

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.

Cardinal Health executives and stock owners

Cardinal Health executives and other stock owners filed with the SEC include:

• Michael Kaufmann,
  Chief Executive Officer, Director
• Victor Crawford,
  Chief Executive Officer - Pharmaceutical Segment
• Jason Hollar,
  Chief Financial Officer
• Stephen Mason,
  Chief Executive Officer - Medical Segment
• Jessica Mayer,
  Chief Legal and Compliance Officer
• Michael C. Kaufmann,
  CEO & Director
• David Evans,
  Independent Director
• Victor L. Crawford,
  Chief Exec. Officer of Pharmaceutical Segment
• Jason M. Hollar,
  Chief Financial Officer
• Stephen M. Mason,
  Chief Exec. Officer of Medical Segment
• Jessica L. Mayer,
  Chief Legal & Compliance Officer
• Gregory Kenny,
  Independent Non-Executive Chairman of the Board
• Carrie Cox,
  Independent Director
• John Losh,
  Independent Director
• Bruce Downey,
  Independent Director
• Dean Scarborough,
  Independent Director
• Patricia Hemingway Hall,
  Independent Director
• John Weiland,
  Independent Director
• Calvin Darden,
  Independent Director
• Nancy Killefer,
  Independent Director
• Akhil Johri,
  Independent Director
• Sheri Edison,
  Independent Director
• Brian Rice,
  Executive Vice President, Chief Information Officer and Customer Support Services
• Ola Snow,
  Chief Human Resource Officer
• Dr. Michele A. M. Holcomb Ph.D.,
  Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer
• Brian S. Rice,
  Chief Information Officer, Exec. VP & Global Bus. Services
• Craig Cowman,
  Exec. VP of Global Sourcing
• Kevin Moran,
  VP of Investor Relations
• Patricia M. English,
  Sr. VP & Chief Accounting Officer
• Pamela O. Kimmet,
  Chief Human Resources Officer
• Michele Holcomb,
  EVP - Strategy & Corp. Dev.
• Falk T Stephen,
  EVP, Gen. Counsel & Corp. Sec.
• David P King,
  Director
• Craig S Morford,
  Chief Compliance Officer
• Colleen F. Arnold,
  Director
• Stuart G Laws,
  SVP & Chief Accounting Officer
• Donald M Jr. Casey,
  CEO, Medical Segment
• Clayton M Jones,
  Director
• David J Anderson,
  Director
• Patricia Morrison,
  Chief Information Officer
• Meghan Fitzgerald,
  EVP, Strategy & Health Policy
• Carole S Watkins,
  EVP - Human Resources
• Jon L Giacomin,
  CEO, Medical Segment
• George S Barrett,
  Chairman and CEO
• J Michael Losh,
  Director
• Deborah Weitzman,
  CEO, PSS Segment
• Jeffrey William Henderson,
  Executive Vice President
• David W Raisbeck,
  Director
• Michael A Lynch,
  CEO, Medical Segment
• Glenn Britt,
  Director
• Jean G Spaulding,
  Director
• John F Finn,
  Director
• Richard C Notebaert,
  Director
• Mark R Blake,
  EVP -- Strategy & Corp. Dev.
• James J Md Mongan,
  Director
• Jorge M Gomez,
  Chief Financial Officer
• Michael D Ohalleran,
  Director
• Vivek Jain,
  EVP - Corp Develop. & Strategy
• George H Conrades,
  Director
• Ivan K Fong,
  EVP, CLO & Secretary
• Robert D Walter,
  Chairman and CEO
• David L Schlotterbeck,
  Chmn & CEO-Clncl Techn & Svcs
• John B Mccoy,
  Director
• Philip L Francis,
  Director
• Matthew D Walter,
  Director
• R Kerry Clark,
  President and CEO
• Daniel J Walsh,
  EVP, Chf Ethcs & Compl Offcr
• Mark W Parrish,
  EVP; Group Pres.-Pharm. Distr.
• John F Havens,
  Director
• David Bing,
  Director
• Gary S Jensen,
  SVP - Corporate Controller
• Robert L Gerbig,
  Director
• Ronald K Labrum,
  CEO-Healthcare Supply Chn Svc
• Brendan A Ford,
  EVP - Corp. Development
• Anthony J Rucci,
  EVP & Chief Admin. Officer
• Joseph C Papa,
  Chmn & CEO, Pharm Techn & Svcs
• Stephen S Thomas,
  EVP-Group Pres.-AIS
• Gary D Dolch,
  EVP - Quality & Reg. Affairs
• George L Fotiades,
  President & COO
• Eric Slusser,
  SVP-Finance, CAO & Cntrllr
• Paul S Williams,
  EVP, CLO & Secretary
• Jody R Davids,
  EVP & CIO
• Richard J Miller,
  EVP & CFO
• Aaron E Alt,
  Chief Financial Officer
• Robert Azelby,
  Director
• Patricia M English,
  Chief Accounting Officer
• Christine Mundkur,
  Director
• Steven Barg,
  Director
• Michelle Brennan,
  Director
• Michelle D. Greene,
  Chief Information Officer
• Mary C. Scherer,
  Chief Accounting Officer